Toll-Like受体 3兔多克隆抗体(Toll-Like Receptor 3 Rabbit pAb) Toll-Like受体 3兔多抗(760963ES)
产品应用
The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It may thus play a role in host defense against viruses. Use of alternative polyadenylation sites to generate different length transcripts has been noted for this gene.
推荐稀释比 WB:1/500-1/1000;IHC:1/50-1/100

Western blot analysis of TLR3 in Hela, Raji, K562 lysates using Toll-Like Receptor 3 antibody.

Immunohistochemistry analysis of paraffin-embedded Human lung cancer using Toll-Like Receptor 3 antibody. High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
-25 ~ -15℃保存,收到货之后有效期1年,避免反复冻融。
【应用方向】糖酵解重编程抗体推荐:炎症细胞活化的代谢开关与科研靶点解析
100
2026-10-09
【应用方向】免疫抑制与组织修复的关键受体:TNFRSF1B (TNFR2)
431
2026-07-29
【应用方向】单细胞表观测序中的抗体应用
542
2026-07-29
【应用方向】抗体应用研究--细胞氧化应激
505
2026-07-21
【应用案例】细胞内蛋白流式细胞术protocol(甲醇方法)
892
2026-08-03
【选购指南】类器官研究之构建与起始细胞鉴定抗体推荐
919
2026-07-21
【选购指南】类器官研究之功能成熟度评估抗体推荐
704
2026-07-21
【应用方向】炎症小体-疼痛通路:解码慢性疼痛的“隐形推手”
597
2026-07-21
【应用方向】趋化因子信号传导通路——身体“信号导航”解析
707
2026-07-21
【选购指南】重度抑郁症(MDD)通路研究抗体推荐
705
2026-07-21
【选购指南】帕金森病(PD)代谢机制核心抗体研究指南
684
2026-07-21
【应用方向】抗体助力心脏免疫研究——解锁心衰防治新方向
654
2026-07-21
【应用方向】抗体助力心肌肥大与心衰研究:从基础探索到科研应用
669
2026-07-21
【应用方向】抗体助力癌症代谢通路研究——肿瘤代谢科普与研究工具指南
712
2026-07-21
【应用方向】多发性硬化症中神经传导通路抗体推荐
404
2026-05-06





